Bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic Pregnancy and Breastfeeding Warnings
Brand names: Cortisporin Ophthalmic Ointment, Cortomycin Eye Ointment, Neo-Poly-Bac, Neo-Polycin HC, Neotricin HC, Ocu-Cort, Triple Antibiotic HC Ophthalmic Ointment
Medically reviewed by Drugs.com. Last updated on Aug 11, 2023.
Bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic Pregnancy Warnings
This drug should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.
US FDA pregnancy category: C
Animal studies with this combination drug have not been reported. Corticosteroids have been found to be teratogenic in rabbits when applied topically at concentrations of 0.5% and 15%. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Bacitracin / hydrocortisone / neomycin / polymyxin b ophthalmic Breastfeeding Warnings
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
It is unknown whether topically administered corticosteroids could result in sufficient systemic absorption to produce detectable levels in breast milk; however, systemically administered corticosteroids may appear in breast milk and could suppress growth, interfere with endogenous corticosteroid production, or cause untoward effects.
See also
References for pregnancy information
- (2022) "Product Information. Cortisporin Ophthalmic (bacitracin/HC/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc
References for breastfeeding information
- (2022) "Product Information. Cortisporin Ophthalmic (bacitracin/HC/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.